Survey and Research Archives | Page 3 of 98 | Be Korea-savvy

Archive by category Survey and Research

Bright Peak Therapeutics Presents New Data at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Bright Peak Therapeutics Presents New Data at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

– BPT958, a bifunctional PD-1 immunoconjugate with a masked IL-2 payload designed to be processed specifically in the tumor microenvironment - –In preclinical models, BPT958 induces potent antitumor activity with minimal systemic activation - BASEL, Switzerland and SAN DIEGO, Nov. 08, 2024 (Korea Bizwire) – Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering [...]

AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designations for AB-1003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9

AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designations for AB-1003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9

First patient dosed in Phase 1/Phase 2 LION-CS101 trial of AB-1003 in August 2023, with enrollment continuing Research Triangle Park, N.C., Nov. 07, 2024 (Korea Bizwire) – Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that AB-1003 (also known as LION-101) has received [...]

Monsha’at: Day 2 of Biban 2024 raises the bar for Saudi entrepreneurship with over 1.35bn Saudi Riyals worth of agreements launched

Monsha’at: Day 2 of Biban 2024 raises the bar for Saudi entrepreneurship with over 1.35bn Saudi Riyals worth of agreements launched

RIYADH, Saudi Arabia, Nov. 07, 2024 (Korea Bizwire) – 20 agreements worth more than 1.35bn Saudi Riyals were signed on the second day of Biban24 forum. In line with Vision 2030, these partnerships and agreements were launched to empower Saudi Arabia’s thriving community of entrepreneurs and advance entrepreneurship in the Kingdom and beyond. Day 2 [...]

ATNi Launches 5th Global Access to Nutrition Index as Industry and Policy Makers Grapple with Food Polycrisis

ATNi Launches 5th Global Access to Nutrition Index as Industry and Policy Makers Grapple with Food Polycrisis

UTRECHT, The Netherlands, Nov. 07, 2024 (Korea Bizwire) – Today, ATNi launches the 5th edition of the Global Access to Nutrition Index, the largest yet, assessing the world’s 30 largest food and beverage manufacturers and over 52,000 products, representing 23% global market share. One in five deaths globally is associated with a poor diet. One out [...]

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors

Global Phase 1 clinical trial will evaluate the safety and tolerability of ZW191 in treatment of advanced cancers including ovarian, endometrial, and non-small cell lung cancers VANCOUVER, British Columbia, Nov. 05, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard [...]

Deutsche Aircraft and RTX’s Pratt & Whitney Canada collaborate to ensure 100% SAF readiness for the D328eco™, building on 40-year relationship and recent D328® Uplift test flights with synthetic fuel

Deutsche Aircraft and RTX’s Pratt & Whitney Canada collaborate to ensure 100% SAF readiness for the D328eco™, building on 40-year relationship and recent D328® Uplift test flights with synthetic fuel

Vancouver, Nov. 04, 2024 (Korea Bizwire) – Deutsche Aircraft, and Pratt & Whitney Canada, announce the conclusion of a series of five emission and contrail measurement flights on a D328® UpLift research aircraft using a fully synthetic Fischer-Tropsch fuel, preparing for the use of future sustainable aviation fuels (SAF) produced using Power-to-Liquid (PtL) technology. This [...]

Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease

Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular Institute of the South successfully treats first patient in the U.S. using Philips’ innovative laser system, marking a milestone in advancing personalized care [...]

Bitget Wallet Lite Hits 6 Million Users in Days, Now The Largest Telegram Wallet

Bitget Wallet Lite Hits 6 Million Users in Days, Now The Largest Telegram Wallet

VICTORIA, Seychelles, Nov. 04, 2024 (Korea Bizwire) – Bitget Wallet, a leading non-custodial Web3 wallet, has launched Bitget Wallet Lite, a multi-chain wallet integrated into Telegram, offering users a seamless, secure way to purchase, manage, and transfer crypto assets directly within the messaging app. Since its soft launch on October 28th, Bitget Wallet Lite has attracted over [...]

Colliers named one of Forbes’ World’s Best Employers 2024

Colliers named one of Forbes’ World’s Best Employers 2024

Second consecutive appearance highlights strong corporate culture TORONTO, Nov. 04, 2024 (Korea Bizwire) – Leading diversified professional services and investment management company Colliers (NASDAQ and TSX: CIGI) has been named by Forbes as one of the World’s Best Employers 2024 for the second consecutive year. As the only global, full-service commercial real estate firm on the list, [...]

Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition

Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition

IMPACT-TD Registry, the largest study evaluating holistic effects of tardive dyskinesia (TD), highlights that there is a high burden of TD on quality of life regardless of a person’s underlying mental health condition Registry revealed fewer patients with psychotic disorders (36%) received TD diagnoses compared to those with mood disorders (50%) Teva continues to further [...]